€24.70
1.44% today
Xetra, Apr 01, 05:35 pm CET
ISIN
DE000STRA555
Symbol
SBS
Index
Sector

STRATEC Stock price

€24.70
-3.85 13.49% 1M
-18.80 43.22% 6M
-5.10 17.11% YTD
-15.50 38.56% 1Y
-98.50 79.95% 3Y
-47.60 65.84% 5Y
-21.01 45.96% 10Y
Xetra, Closing price Tue, Apr 01 2025
+0.35 1.44%
ISIN
DE000STRA555
Symbol
SBS
Index
Sector

Key metrics

Market capitalization €296.00m
Enterprise Value €415.43m
P/E (TTM) P/E ratio 29.57
EV/FCF (TTM) EV/FCF 15.32
EV/Sales (TTM) EV/Sales 1.66
P/S ratio (TTM) P/S ratio 1.18
P/B ratio (TTM) P/B ratio 1.30
Dividend yield 2.26%
Last dividend (FY23) €0.55
Revenue growth (TTM) Revenue growth -1.62%
Revenue (TTM) Revenue €250.54m
EBIT (operating result TTM) EBIT €20.14m
Free Cash Flow (TTM) Free Cash Flow €27.11m
Cash position €33.11m
EPS (TTM) EPS €0.82
P/E forward 20.73
P/S forward 1.15
EV/Sales forward 1.62
Show more

Is STRATEC a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

STRATEC Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a STRATEC forecast:

3x Buy
43%
4x Hold
57%

Analyst Opinions

7 Analysts have issued a STRATEC forecast:

Buy
43%
Hold
57%

Financial data from STRATEC

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
251 251
2% 2%
100%
- Direct Costs 183 183
6% 6%
73%
68 68
13% 13%
27%
- Selling and Administrative Expenses 18 18
26% 26%
7%
- Research and Development Expense 10 10
19% 19%
4%
39 39
6% 6%
16%
- Depreciation and Amortization 19 19
13% 13%
8%
EBIT (Operating Income) EBIT 20 20
0% 0%
8%
Net Profit 10 10
17% 17%
4%

In millions EUR.

Don't miss a Thing! We will send you all news about STRATEC directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

STRATEC Stock News

AD HOC NEWS
14 days ago
STRATEC SE / DE000STRA555
AD HOC NEWS
14 days ago
Stratec DE000STRA555 verschiebt die Veröffentlichung seines Geschäftsberichts für 2024.
AD HOC NEWS
14 days ago
STRATEC SE / DE000STRA555
More STRATEC News

Company Profile

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Smart Consumables, and Other Activities. The Instrumentation segment consults, designs, develops and produces fully automated solutions for its partners in the fields of diagnostics including blood banking. The Diatron segment comprises the business with systems, system components, consumables and tests in the low throughput hematology and clinical chemistry segment. The Smart Consumables segment includes the business with developing and manufacturing smart consumables in the fields of diagnostics, life sciences, and medical technology. The Other Activities segment covers the development of work flow software for networking several analyzer systems and the development and sale of scientific materials and technologies. The company was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany.

Head office Germany
CEO Marcus Wolfinger
Employees 1,522
Founded 1979
Website www.stratec.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today